CYTOSORBENTS CORPORATION: 10-Q filed 2018-11-06

Name: CYTOSORBENTS CORPORATION: 10-Q filed 2018-11-06
Creator: CYTOSORBENTS CORPORATION

What CYTOSORBENTS CORPORATION reported in its quarterly report filed 2018-11-06 (fiscal Q3 2018): 38 published measures, 98 facts as tagged in accession 0001144204-18-057624.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-11-06
Fiscal period: fiscal Q3 2018
Accession: 0001144204-18-057624 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-09-30	34,249,471	USD
At 2017-12-31	24,103,307	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-09-30	14,178,742	USD
At 2017-12-31	13,840,472	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-09-30	20,070,729	USD
At 2017-12-31	10,262,835	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-09-30	24,911,264	USD
At 2017-12-31	17,321,862	USD
At 2017-09-30	15,400,348	USD
At 2016-12-31	5,245,178	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-3,004,762	USD	92
2018-01-01 to 2018-09-30	-11,808,000	USD	273
2017-07-01 to 2017-09-30	-2,054,279	USD	92
2017-01-01 to 2017-09-30	-5,313,780	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-8,132,538	USD	273
2017-01-01 to 2017-09-30	-6,051,221	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	495,526	USD	273
2017-01-01 to 2017-09-30	579,944	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	5,742,973	USD	92
2018-01-01 to 2018-09-30	16,423,063	USD	273
2017-07-01 to 2017-09-30	3,824,299	USD	92
2017-01-01 to 2017-09-30	10,504,043	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	16,990,392	USD	273
2017-01-01 to 2017-09-30	17,215,470	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-1,196,832	USD	273
2017-01-01 to 2017-09-30	-1,096,147	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-09-30	-164,120,636	USD
At 2017-12-31	-152,312,636	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2018-07-01 to 2018-09-30	USD	92
2018-01-01 to 2018-09-30	USD	273
2017-07-01 to 2017-09-30	USD	92
2017-01-01 to 2017-09-30	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-09-30	1,677,049	USD
At 2017-12-31	1,402,782	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	2,863,739	USD	273
2017-01-01 to 2017-09-30	1,851,020	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-2,710,621	USD	92
2018-01-01 to 2018-09-30	-9,999,662	USD	273
2017-07-01 to 2017-09-30	-2,149,045	USD	92
2017-01-01 to 2017-09-30	-6,037,431	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-09-30	29,950,318	USD
At 2017-12-31	20,739,340	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-09-30	4,261,303	USD
At 2017-12-31	7,848,331	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-09-30	1,859,328	USD
At 2017-12-31	1,244,411	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2018-09-30	3,642,510	USD
At 2017-12-31	2,205,859	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	6,400,898	USD	92
2018-01-01 to 2018-09-30	21,016,530	USD	273
2017-07-01 to 2017-09-30	4,456,480	USD	92
2017-01-01 to 2017-09-30	12,288,117	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2018-09-30	779,425	USD
At 2017-12-31	795,657	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	3,690,277	USD	92
2018-01-01 to 2018-09-30	11,016,868	USD	273
2017-07-01 to 2017-09-30	2,307,435	USD	92
2017-01-01 to 2017-09-30	6,250,686	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	4,040,847	USD	92
2018-01-01 to 2018-09-30	14,426,272	USD	273
2017-07-01 to 2017-09-30	3,574,984	USD	92
2017-01-01 to 2017-09-30	9,771,182	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	1,943,417	USD	92
2018-01-01 to 2018-09-30	5,299,475	USD	273
2017-07-01 to 2017-09-30	643,193	USD	92
2017-01-01 to 2017-09-30	1,555,491	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-09-30	31,633,432	shares
At 2017-12-31	28,973,679	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2018-09-30	184,089,635	USD
At 2017-12-31	162,907,482	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2018-09-30	70,097	USD
At 2017-12-31	-360,985	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2018-09-30	9,917,439	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-09-30	2,622,104	USD
At 2017-12-31	1,961,185	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-09-30	617,119	USD
At 2017-12-31	415,962	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2018-09-30	35,113	USD
At 2017-12-31	30,380	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-2,905,476	USD	92
2018-01-01 to 2018-09-30	-11,376,918	USD	273
2017-07-01 to 2017-09-30	-2,334,357	USD	92
2017-01-01 to 2017-09-30	-6,335,741	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-3,004,762	USD	92
2018-01-01 to 2018-09-30	-11,808,000	USD	273
2017-07-01 to 2017-09-30	-2,054,279	USD	92
2017-01-01 to 2017-09-30	-5,649,511	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-294,141	USD	92
2018-01-01 to 2018-09-30	-1,808,338	USD	273
2017-07-01 to 2017-09-30	94,766	USD	92
2017-01-01 to 2017-09-30	723,651	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	667,427	USD	273
2017-01-01 to 2017-09-30	407,347	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2017-04-01 to 2017-04-11	10,300,000	USD	11

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	1,518,237	USD	273
2017-01-01 to 2017-09-30	803,348	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-14,259	USD	273
2017-01-01 to 2017-09-30	227,882	USD	273

Inspect the source

Entity: CYTOSORBENTS CORPORATION / CIK 0001175151
Captured: 2026-09-20T07:44:44.168Z
SEC response SHA-256: 8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))